Vienna

• A model of a sterile, self-limiting, acute inflammatory response in healthy volunteers using lipopolysaccharides – a platform trial Recruiting
  2024-518768-11-02 3 2023-05-19 Healthy volunteers
• Single dose pharmacokinetics of selected antibiotics in plasma and soft tissues of healthy volunteers. Recruiting
  2024-518260-13-00 3 2023-05-15 Healthy volunteers
• The ACTION Study: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy Recruiting
  2022-502051-56-00 5 2023-04-28 H3 K27M-mutant diffuse glioma
• EPI/HIS-trial Recruiting
  2024-517017-33-00 3 2023-04-04 No medical condition, it is a study in healthy volunteers
• Aspirin versus placebo in twin pregnancies for preeclampsia prevention: A multicentre, randomised, double-blind, placebo-controlled trial (A … Recruiting
  2023-503698-40-00 5 2023-03-23 Preeclampsia
• MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer Recruiting
  2024-511219-78-00 5 2023-02-28 epithelial ovarian cancer
• Effect of Dupilumab an mucus plugs and inflammatory patterns in sEvere asThmAtiC paTients — a Pilot Study (DETACT) Recruiting
  2024-517567-23-00 11 2023-02-02 severe asthma
• Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients Recruiting
  2024-518226-32-00 6 2023-01-05 Major Depression
• Antibiotic pharmacokinetics in women with twin pregnancy Recruiting
  2024-518564-12-00 6 2023-01-05 Pregnancy
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants with Ulcerative Colitis or Crohn’s Disease (SHINE-ON) Recruiting
  2023-506239-14-00 5 2022-12-13 Crohn’s Disease
• International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting
  2022-500783-35-00 5 2022-12-06 Acute Myeloid Leukemia
• A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting
  2024-514180-25-00 5 2022-11-21 unresectable or metastatic HER2+ colorectal cancer
• MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex … Recruiting
  2024-514139-50-00 5 2022-11-14 Multiple myeloma
• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece … Recruiting
  2023-504885-50-00 5 2022-11-07 Treatment of children with chronic kidney disease and proteinuria
• A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination … Recruiting
  2023-503442-30-00 5 2022-10-14 Multiple Myeloma
• A multicenter, double-blind, randomized study to evaluate the effects of tasimelteon vs. placebo in participants with Delayed Sleep-Wake Pha … Recruiting
  2024-516962-13-00 5 2022-09-23 Delayed Sleep-Wake Phase Disorder (DSWPD)
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia … Recruiting
  2023-510384-36-00 5 2022-09-13 Newly Diagnosed Multiple Myeloma
• A prospective, single-center phase I pilot study to assess the tissue activity of multidrug resistance-associated protein 1 with positron em … Recruiting
  2024-517851-11-00 1 2022-09-05 Investigation in healthy volunteers and Alzheimer's disease patients
• Asciminib Roll-over Study Recruiting
  2023-507557-16-00 5 2022-08-31 chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
• A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting
  2023-507699-38-00 5 2022-08-30 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
• Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial Recruiting
  2024-518212-40-00 5 2022-08-25 Obsessive Compulsive Disorder (OCD)
• Ketamine study Recruiting
  2024-519097-39-01 5 2022-06-23 Negative and depressive symptoms in schizophrenia / schizoaffective di
• International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting
  2022-501180-40-00 5 2022-06-17 Ewing Sarcoma
• Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting
  2024-513412-10-00 9 2022-05-11 Anaplastic Large Cell Lymphoma (ALCL)

Showing 361–384 of 828 trials